Verse Medical builds software infrastructure for delivering hospital-quality care at home. The company operates as an AI-enabled Durable Medical Equipment (DME) provider, connecting providers, payors and patients across the United States. It is active in 47 states and partners with major US health systems. The company is at Series C stage and is backed by investors including General Catalyst, SignalFire and Sapphire Ventures.
The Verse platform consolidates referrals, orders and communications into a single system, replacing processes such as faxing and phone tag. The company reports that the platform saves clinics 10-15 hours per week. Technical work spans healthcare software infrastructure, AI and machine learning, care coordination platforms, referral and order management systems, and automation of communications workflows.
Verse Medical's stated mission is to reform a healthcare system dependent on outdated technology and to make high-quality in-home care easy and accessible. The company describes itself as well-funded and growing rapidly, with ambitious expansion plans.
